Celanese Receives Unconditional Approval from European Commission for Acquisition of Acetex Corporation
"We are very pleased to receive the European Commission's approval and to move forward with successfully completing our acquisition of this first-class manufacturer of acetyl chemicals and specialty polymers," said David Weidman, chief executive officer and president of Celanese. "Acetex will play a key role in our strategy of increasing the productivity of our acetyls chain of products in order to provide an even more cost-efficient and reliable supply to our customers globally."
"The acquisition also improves our production capabilities in Europe on key product platforms and provides opportunities for future growth through Acetex's Saudi Arabian acetyls joint venture. In addition, we expect to achieve substantial synergies in the areas of manufacturing processes, supply chain, sales and administration," continued David Weidman.
In October 2004, Celanese offered to acquire the approximately 35.4 million fully diluted Acetex shares at a purchase price of CDN $9.00 per share at a cost of CDN $318 million (US $261 million) and to assume Acetex's CDN $282 million (US $231 million) in debt.
Celanese intends to purchase the outstanding shares out of its cash and will assume the existing debt of Acetex. The company also intends to have Acetex exercise its option to redeem the Acetex 10-7/8% senior notes due 2009 either with cash or, if necessary, Celanese's existing senior credit facilities. The redemption is expected to take place approximately 30 days from closing. Celanese originally proposed to finance this acquisition entirely through debt.
"Our cash position gives us the flexibility to strategically use cash to return value to shareholders," said C. J. Nelson, executive vice president and chief financial officer. "By financing the transaction in this manner, we are eliminating the need to increase our debt to the levels we forecasted when we announced the acquisition, and calling the bonds will lower Celanese's overall cost of borrowed capital."
In 2004, Acetex had total net sales of approximately US $530 million and employed about 900 people worldwide. Acetex's operations consist of an acetyls business with plants in Europe and a North-American specialty polymers and film business. The acetyl business includes acetic acid, vinyl acetate monomer and polyvinyl alcohol. These chemicals and their derivatives are used in a wide range of applications in the construction, packaging, automotive, pharmaceutical and textile industries. The specialty polymers developed by Acetex are used to manufacture a variety of plastic products, and Acetex's films business focuses on products for the agricultural, horticultural and construction industries. Acetex also previously concluded an agreement for a joint venture project to build an acetyls complex in Saudi Arabia and has commenced the technical planning for this facility.
Topics
Organizations
Other news from the department business & finance
These products might interest you
Spinsolve Benchtop NMR by Magritek
Spinsolve Benchtop NMR
Spinsolve is a revolutionary multinuclear NMR spectrometer that provides the best performance
Eclipse by Wyatt Technology
FFF-MALS system for separation and characterization of macromolecules and nanoparticles
The latest and most innovative FFF system designed for highest usability, robustness and data quality
HYPERION II by Bruker
FT-IR and IR laser imaging (QCL) microscope for research and development
Analyze macroscopic samples with microscopic resolution (5 µm) in seconds
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.